AGP Executive Report
Last update: 4 hours agoBrazilian Market: MediPharm Labs has launched a full-spectrum CBD oral oil for medicinal use in Brazil, manufactured in Canada and authorized by ANVISA. The deal marks a step into a tightly regulated, fast-growing market. U.S. Hemp Policy: A former White House adviser alleges Susie Wiles influenced policy to delay a federal ban on intoxicating hemp products, citing her family’s business ties. The claims are disputed, and Congress faces a December deadline to act or postpone the ban. Patient Access: South Africa’s freeze on Section 21 cannabis approvals is raising concerns about treatment access for vulnerable patients. CBD Rules: An EU court ruling says CBD products cannot be labelled organic, creating another regulatory hurdle for brands seeking to market cannabinoid products across Europe.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.